Get the Stockscreener App
1.41
0.71%
0.01
Pre-market:
1.39
-0.02
-1.42%
Pmv Pharmaceuticals Inc stock is traded at $1.41, with a volume of 229.04K.
It is up +0.71% in the last 24 hours and up +0.71% over the past month.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.40
Open:
$1.4
24h Volume:
229.04K
Relative Volume:
0.19
Market Cap:
$74.72M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.41
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
-9.62%
1M Performance:
+0.71%
6M Performance:
+42.42%
1Y Performance:
-13.50%
1-Day Range:
$1.38
$1.43
1-Week Range:
$1.38
$1.63
52-Week Range:
$0.81
$1.84
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Name
Pmv Pharmaceuticals Inc
Sector
Industry
Phone
(609) 642-6670
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.41 | 74.19M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-08-24 | Upgrade | Oppenheimer | Perform → Outperform |
| May-13-24 | Initiated | Craig Hallum | Buy |
| Apr-12-24 | Initiated | Jefferies | Buy |
| Dec-27-23 | Initiated | Ladenburg Thalmann | Buy |
| Mar-02-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-22-21 | Upgrade | Goldman | Neutral → Buy |
| Aug-19-21 | Initiated | Oppenheimer | Perform |
| Aug-02-21 | Initiated | Guggenheim | Buy |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Oct-20-20 | Initiated | Cowen | Outperform |
| Oct-20-20 | Initiated | Evercore ISI | Outperform |
| Oct-20-20 | Initiated | Goldman | Neutral |
View All
Pmv Pharmaceuticals Inc Stock (PMVP) Latest News
PMV Pharmaceuticals Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$75m - simplywall.st
Is PMV Pharmaceuticals Inc. stock poised for growthQuarterly Growth Report & Free Reliable Trade Execution Plans - newser.com
Is PMV Pharmaceuticals Inc. stock resilient to inflationJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
Real time social sentiment graph for PMV Pharmaceuticals Inc.July 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
Published on: 2025-11-02 07:20:04 - newser.com
Published on: 2025-11-02 06:42:35 - newser.com
Applying chart zones and confluence areas to PMV Pharmaceuticals Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com
Can PMV Pharmaceuticals Inc. stock deliver surprise earnings beatWeekly Gains Summary & Technical Entry and Exit Tips - newser.com
Will PMV Pharmaceuticals Inc. stock benefit from automationMarket Activity Report & Free Fast Gain Swing Trade Alerts - newser.com
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Sees Significant Growth in Short Interest - MarketBeat
Published on: 2025-11-01 11:39:40 - newser.com
Is PMV Pharmaceuticals Inc. building a consolidation baseWeekly Market Outlook & Entry Point Confirmation Signals - newser.com
What drives PMV Pharmaceuticals Inc stock priceTrade Execution Strategies & Small Budget Trading Plans - earlytimes.in
Orbimed Advisors LLC Reduces Stake in PMV Pharmaceuticals Inc - GuruFocus
How institutional buying supports PMV Pharmaceuticals Inc. stock2025 Big Picture & Accurate Entry and Exit Point Alerts - newser.com
Will PMV Pharmaceuticals Inc. bounce back from current supportMarket Risk Analysis & Free Low Drawdown Momentum Trade Ideas - newser.com
PMV Pharmaceuticals (PMVP) Expected to Announce Earnings on Thursday - MarketBeat
Using fundamentals and technicals on PMV Pharmaceuticals Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com
PMV Pharmaceuticals (NASDAQ:PMVP) Major Shareholder Orbimed Advisors Llc Sells 1,000,000 Shares - MarketBeat
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Using AI based signals to follow PMV Pharmaceuticals Inc.Trade Risk Summary & Daily Stock Trend Watchlist - newser.com
Can PMV Pharmaceuticals Inc. stock sustain market leadershipPortfolio Return Summary & Daily Oversold Bounce Ideas - fcp.pa.gov.br
How rising interest rates impact PMV Pharmaceuticals Inc. stockSell Signal & Daily Oversold Stock Bounce Ideas - newser.com
OrbiMed Advisors sells PMV Pharma (PMVP) shares for $1.52 million - Investing.com India
OrbiMed Advisors sells PMV Pharma (PMVP) shares for $1.52 million By Investing.com - Investing.com South Africa
PMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586 - TipRanks
Is PMV Pharmaceuticals Inc. stock positioned well for digital economySwing Trade & Intraday High Probability Alerts - fcp.pa.gov.br
Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pmv Pharmaceuticals Inc Stock (PMVP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Oct 23 '25 |
Sale |
1.52 |
1,000,000 |
1,520,000 |
4,975,291 |
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):